Literature DB >> 1394127

Tumor progression in vivo: increased soybean agglutinin lectin binding, N-acetylgalactosamine-specific lectin expression, and liver metastasis potential.

M R Reese1, D A Chow.   

Abstract

Tumors which grew out from threshold s.c. inocula of L5178Y-F9 and SL2-5 murine T-cell lymphomas in syngeneic DBA/2 mice exhibited a unified natural defense-resistant phenotype including an increased tumorigenicity and correlating reductions in susceptibility to natural antibodies, natural killer cells, and activated macrophages in vitro. The metastatic potential and cell surface saccharide expression of these cells were determined to assess the impact of growth from a small tumor focus in vivo on subsequent metastatic ability and to determine whether there was any association with changes in cell surface carbohydrates, which have been implicated now for many years in tumor development. A significantly increased liver-colonizing ability was observed following i.v. injection. The most consistent change in cell surface saccharide expression detected in studies using five lectins was an increase in N-acetyl-D-galactosamine (D-GalNAc)-specific soybean agglutinin (SBA) binding. The log of experimental liver metastasis, SBA binding, and the percentage of hepatocyte rosetting of the parental and in vivo-selected cells exhibited significant direct correlations. While inhibition of rosetting with in vivo-selected lines by D-GalNAc and galactose was consistent with the involvement of the D-galactose/D-GalNAc-specific hepatocyte receptor, preincubation of the tumor cells but not hepatocytes with D-GalNAc inhibited hepatocyte rosetting and D-GalNAc inhibited homotypic tumor cell binding. These data suggest a role for a saccharide-specific, lectin-like receptor on tumor cells in both interactions and therefore in the increased experimental liver metastasis. Furthermore, the increased expression of D-GalNAc-inhibitable SBA binding sites on the in vivo-selected variants should increase the homotypic binding by the D-GalNAc-specific lectin-like receptors on the tumor cells providing a rationale for the direct relationship observed between increased SBA binding and i.v. metastatic potential.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394127

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  The development, characterization, and demonstration of a novel strategy for purification of recombinant proteins expressed in plants.

Authors:  Reynald Tremblay; Hong Diao; Norm Huner; Anthony M Jevnikar; Shengwu Ma
Journal:  Transgenic Res       Date:  2011-03-02       Impact factor: 2.788

Review 2.  Glycobiology and medicine: an introduction.

Authors:  J Axford
Journal:  J R Soc Med       Date:  1997-05       Impact factor: 5.344

3.  GalNAc-Tyrosine Is a Ligand of Plant Lectins, Antibodies, and Human and Murine Macrophage Galactose-Type Lectins.

Authors:  Ruslan Gibadullin; David Wayne Farnsworth; Joseph J Barchi; Jeffrey C Gildersleeve
Journal:  ACS Chem Biol       Date:  2017-07-14       Impact factor: 5.100

4.  Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies.

Authors:  Oyindasola Oyelaran; Qian Li; David Farnsworth; Jeffrey C Gildersleeve
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.